Korro Bio (KRRO) EPS (Weighted Average and Diluted) (2022 - 2025)
Historic EPS (Weighted Average and Diluted) for Korro Bio (KRRO) over the last 4 years, with Q3 2025 value amounting to -$1.92.
- Korro Bio's EPS (Weighted Average and Diluted) rose 1504.42% to -$1.92 in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.41, marking a year-over-year decrease of 10668.66%. This contributed to the annual value of -$9.38 for FY2024, which is 8233.57% up from last year.
- Per Korro Bio's latest filing, its EPS (Weighted Average and Diluted) stood at -$1.92 for Q3 2025, which was up 1504.42% from -$2.74 recorded in Q2 2025.
- In the past 5 years, Korro Bio's EPS (Weighted Average and Diluted) registered a high of $147.86 during Q4 2023, and its lowest value of -$225.59 during Q4 2022.
- Its 4-year average for EPS (Weighted Average and Diluted) is -$22.77, with a median of -$2.44 in 2024.
- Over the last 5 years, Korro Bio's EPS (Weighted Average and Diluted) had its largest YoY gain of 16554.37% in 2023, and its largest YoY loss of 1173272.73% in 2023.
- Korro Bio's EPS (Weighted Average and Diluted) (Quarter) stood at -$225.59 in 2022, then surged by 165.54% to $147.86 in 2023, then tumbled by 101.61% to -$2.38 in 2024, then grew by 19.43% to -$1.92 in 2025.
- Its EPS (Weighted Average and Diluted) was -$1.92 in Q3 2025, compared to -$2.74 in Q2 2025 and -$2.49 in Q1 2025.